Nationwide Fund Advisors’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-25,154
| Closed | -$406K | – | 946 |
|
|
2017
Q3 | $406K | Sell |
25,154
-681
| -3% | -$11K | ﹤0.01% | 2286 |
|
|
2017
Q2 | $358K | Buy |
25,835
+3,863
| +18% | +$53.5K | ﹤0.01% | 2347 |
|
|
2017
Q1 | $330K | Buy |
21,972
+2,233
| +11% | +$33.5K | ﹤0.01% | 2372 |
|
|
2016
Q4 | $259K | Sell |
19,739
-991
| -5% | -$13K | ﹤0.01% | 2494 |
|
|
2016
Q3 | $357K | Hold |
20,730
| – | – | ﹤0.01% | 2338 |
|
|
2016
Q2 | $374K | Buy |
20,730
+1,920
| +10% | +$34.6K | ﹤0.01% | 2304 |
|
|
2016
Q1 | $357K | Sell |
18,810
-405
| -2% | -$7.69K | ﹤0.01% | 2266 |
|
|
2015
Q4 | $513K | Buy |
19,215
+508
| +3% | +$13.6K | ﹤0.01% | 2108 |
|
|
2015
Q3 | $456K | Buy |
18,707
+2,708
| +17% | +$66K | ﹤0.01% | 2169 |
|
|
2015
Q2 | $499K | Sell |
15,999
-937
| -6% | -$29.2K | ﹤0.01% | 2247 |
|
|
2015
Q1 | $246K | Sell |
16,936
-661
| -4% | -$9.6K | ﹤0.01% | 2591 |
|
|
2014
Q4 | $177K | Hold |
17,597
| – | – | ﹤0.01% | 2692 |
|
|
2014
Q3 | $147K | Buy |
17,597
+3,183
| +22% | +$26.6K | ﹤0.01% | 2842 |
|
|
2014
Q2 | $178K | Buy |
+14,414
| New | +$178K | ﹤0.01% | 2808 |
|